Article
Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Mar 2016
Mielke Michelle M, Machulda Mary M, Hagen Clinton E, Christianson Teresa J, Roberts Rosebud O, Knopman David S, Vemuri Prashanthi, Lowe Val J, Kremers Walter K, Jack Clifford R, Petersen Ronald C
Abstract excerpt
INTRODUCTION: Few studies have examined the effects of amyloid and apolipoprotein E (APOE) genotype on cognition among middle-aged individuals. METHODS: We included 464 cognitively normal, test-naïve, participants with Pittsburgh compound B positron emission tomography amyloid imaging, mean age of 62.7 (range, 51-71 years), enrolled in the Mayo Clinic Study of Aging. Participants completed multiple cognitive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
